TrialJAMA oncology2018
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.
Eli L Diamond et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
211 papers cite itlatest 60 shown
this paperpooled ittrialcites it